Cargando…
Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
Primary myelofibrosis (PMF) is a chronic myeloproliferative disorder seen in older adults which can present both with hepatosplenomegaly as well as mild nonspecific liver enzyme abnormalities. Mild elevations in bilirubin can occasionally be seen due to both intravascular hemolysis as well as extram...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167125/ https://www.ncbi.nlm.nih.gov/pubmed/35669160 http://dx.doi.org/10.1155/2022/9630996 |
_version_ | 1784720762597277696 |
---|---|
author | Sandhu, Sunny Chaudhry, Hunza Zhang, Sharon Prajapati, Devang |
author_facet | Sandhu, Sunny Chaudhry, Hunza Zhang, Sharon Prajapati, Devang |
author_sort | Sandhu, Sunny |
collection | PubMed |
description | Primary myelofibrosis (PMF) is a chronic myeloproliferative disorder seen in older adults which can present both with hepatosplenomegaly as well as mild nonspecific liver enzyme abnormalities. Mild elevations in bilirubin can occasionally be seen due to both intravascular hemolysis as well as extramedullary hematopoiesis. Marked hyperbilirubinemia as a presenting sign of PMF progression, however, has not been reported. We present the case of a patient with a remote diagnosis of PMF, who presented with marked hyperbilirubinemia with a notable response to ruxolitinib. |
format | Online Article Text |
id | pubmed-9167125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-91671252022-06-05 Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib Sandhu, Sunny Chaudhry, Hunza Zhang, Sharon Prajapati, Devang Case Reports Hepatol Case Report Primary myelofibrosis (PMF) is a chronic myeloproliferative disorder seen in older adults which can present both with hepatosplenomegaly as well as mild nonspecific liver enzyme abnormalities. Mild elevations in bilirubin can occasionally be seen due to both intravascular hemolysis as well as extramedullary hematopoiesis. Marked hyperbilirubinemia as a presenting sign of PMF progression, however, has not been reported. We present the case of a patient with a remote diagnosis of PMF, who presented with marked hyperbilirubinemia with a notable response to ruxolitinib. Hindawi 2022-05-28 /pmc/articles/PMC9167125/ /pubmed/35669160 http://dx.doi.org/10.1155/2022/9630996 Text en Copyright © 2022 Sunny Sandhu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Sandhu, Sunny Chaudhry, Hunza Zhang, Sharon Prajapati, Devang Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib |
title | Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib |
title_full | Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib |
title_fullStr | Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib |
title_full_unstemmed | Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib |
title_short | Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib |
title_sort | marked hyperbilirubinemia associated with primary myelofibrosis responsive to ruxolitinib |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167125/ https://www.ncbi.nlm.nih.gov/pubmed/35669160 http://dx.doi.org/10.1155/2022/9630996 |
work_keys_str_mv | AT sandhusunny markedhyperbilirubinemiaassociatedwithprimarymyelofibrosisresponsivetoruxolitinib AT chaudhryhunza markedhyperbilirubinemiaassociatedwithprimarymyelofibrosisresponsivetoruxolitinib AT zhangsharon markedhyperbilirubinemiaassociatedwithprimarymyelofibrosisresponsivetoruxolitinib AT prajapatidevang markedhyperbilirubinemiaassociatedwithprimarymyelofibrosisresponsivetoruxolitinib |